EP1865910A1 - Compositions de shampooing a base de tensioactifs cationiques - Google Patents

Compositions de shampooing a base de tensioactifs cationiques

Info

Publication number
EP1865910A1
EP1865910A1 EP06701092A EP06701092A EP1865910A1 EP 1865910 A1 EP1865910 A1 EP 1865910A1 EP 06701092 A EP06701092 A EP 06701092A EP 06701092 A EP06701092 A EP 06701092A EP 1865910 A1 EP1865910 A1 EP 1865910A1
Authority
EP
European Patent Office
Prior art keywords
acid
cleaning agent
agent according
group
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP06701092A
Other languages
German (de)
English (en)
Inventor
Erik Schulze Zur Wiesche
Thomas Förster
Sabine Albrechtsen
James Ziming Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP1865910A1 publication Critical patent/EP1865910A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/737Galactomannans, e.g. guar; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8182Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/004Preparations used to protect coloured hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners

Definitions

  • the application relates essentially anionic surfactant-free detergents for keratinic fibers based on specific cationic surfactants and the use of cleaning agents for conditioning and color protection of the hair and for reducing and preventing hair damage.
  • Human hair today is treated with a variety of cosmetic preparations to make the hair shiny and easy to comb, and to give the hair a healthy outer appearance. Due to the diverse treatment of the hair, for example in bleaching, dyeing, tinting and deformation, however, it can lead to an undesirable impairment of the hair structure.
  • the impairment of the hair structure is manifested, for example, in poor wet and dry combability, increased electrostatic charge, increased brittleness, reduced maximum tensile strength and elongation at break of the hair, split ends and an overall deteriorated external appearance of the hair.
  • Cationic polymers alone are unable to provide a satisfactory conditioning effect, particularly with regard to the softness and wet and dry combability of hair.
  • Insoluble, non-volatile silicone oils are widely used as good conditioning agents in hair products, but often leave the hair with a bad, heavy and greasy feel.
  • EP 892 631 B1 has proposed conditioning shampoos which comprise a combination of specific cationic polymers, insoluble silicones and special surfactants. Similar combinations are also known from the documents WO 92/10162 A1, WO 94/031515 A1 and WO 95/2231 1 A1.
  • conditioner shampoos The basis of the prior art conditioner shampoos is based essentially on the same basis: an anionic surfactant system to which cationic polymers and silicones have been added in order to simultaneously achieve a conditioning effect with cleaning.
  • Some hair cleansing and care products also disclose the use of cationic surfactants as cationic conditioning components in anionic surfactant systems.
  • cationic surfactants of a chain length of 16 to 22 carbon atoms were used. Due to their cationic character, they are able to neutralize the anionic hair surfaces and thus reduce the static charge of hair.
  • anionic surfactants which are usually used in hair cleansers, however, these surfactants have a low foaming power, which is why their use was previously limited mainly to hair conditioners and hair treatments. In hair cleaners, they were used at most in low concentrations in addition to anionic and / or amphoteric surfactants.
  • cationic surfactants having a chain length of 8 to 18 carbon atoms have a satisfactory foaming and cleaning power for use as a cleansing surfactant in a hair-cleanser.
  • they have the advantage of being mild on the hair and scalp, leaving no visible film on the hair, improving wet and dry combability, leaving a comfortable feeling on the scalp and being toxicologically safe.
  • shampoos based on these surfactants are able to prevent hair damage and to give colored hair color protection.
  • PEI polyethyleneimine
  • the invention therefore relates to cleaning agents for keratinic fibers which, based on their weight, contain from 1 to 50% by weight of one or more cationic surfactants of the formula (I)
  • R is an alkyl group having 8 to 18 carbon atoms
  • R 1 , R 2 , R 3 are each independently a C r C 3 alkyl group
  • X ' is halogen or methosulfate, and are substantially free of anionic surfactants
  • Substantially free of anionic surfactants according to the invention means that the content of anionic surfactants in the cleaning agents ⁇ 5 wt .-%, preferably ⁇ 3 wt .-% and in particular ⁇ 1, 5 wt .-% is. Commercial products containing anionic surfactants in minor amounts are disregarded.
  • Suitable cationic surfactants according to the invention are those in which the radical R is an alkyl group having 8 to 16 carbon atoms and preferably an alkyl group having 10 to 14 carbon atoms.
  • Particularly suitable cationic surfactants in the context of the invention are cocotrimonium chloride, cocotrimonium methosulfate, laurotronium chloride and / or laurotrimium methosulfate.
  • the cationic surfactants are used in the detergents according to the invention - based on their weight - in an amount of 1 to 50 wt .-% and in particular in an amount of 5 to 30 wt .-%.
  • Detergent according to one of claims 1 to 4 characterized in that it - based on its weight - 0.1 to 5 wt .-%, in particular 0.3 to 3 wt .-% of one or more foam boosters from the group of nonionic and / or contains the amphoteric surfactants.
  • the cleaning agents contain a foam enhancer from the group of the fatty acid alkanolamides, the betaines, the amine oxides and / or the sugar surfactants.
  • betaines examples include cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate,
  • a particularly preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
  • Suitable fatty acid alkanolamides according to the invention are those having fatty acid chain lengths of 8 to 30 carbon atoms. Addition products of ethylene oxide onto fatty acid alkanolamides and fatty amines likewise fall under the term according to the invention.
  • Suitable sugar surfactants according to the invention are alkyl polyglycosides corresponding to the general formula RO - (Z) x , where R is alkyl, Z is sugar and x is the number of sugar units.
  • the alkyl polyglycosides which can be used according to the invention can only contain one particular alkyl radical R. Usually, however, these compounds are prepared starting from natural fats and oils or mineral oils. In this case, the alkyl radicals R are mixtures corresponding to the starting compounds or corresponding to the particular work-up of these compounds.
  • sugar building block Z it is possible to use any desired mono- or oligosaccharides.
  • sugars with 5 or 6 carbon atoms and the corresponding oligosaccharides are used.
  • Such sugars are, for example, glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose and sucrose.
  • Preferred sugar building blocks are glucose, fructose, galactose, arabinose and sucrose; Glucose is particularly preferred.
  • alkyl polyglycosides which can be used according to the invention contain on average from 1.1 to 5 sugar units. Alkyl polyglycosides having x values of 1.1 to 2.0 are preferred. Very particular preference is given to alkyl glycosides in which x is 1: 1 to 1, 8.
  • alkoxylated homologs of said alkyl polyglycosides can also be used according to the invention. These homologs may contain on average up to 10 ethylene oxide and / or propylene oxide units per alkyl glycoside unit.
  • foam boosters for the purposes of the invention are cocamide MEA, cocamide DEA, cocamide MIPA, PEG-2 cocamide, PPG-2 hydroxyethyl cocamide, PPG-2 hydroxyethyl coco / isostearamide, alkylamidopropylbetaine and / or alkylamidopropylamine oxides.
  • the cleaning compositions for the healing and prevention of hair damage further contain 0.05 to 2 wt .-%, in particular 0.1 to 1 wt .-% of a polyalkyleneimine.
  • a particularly suitable polyalkyleneimine according to the invention is polyethyleneimine (PEI).
  • the detergents according to the invention also contain a thickener. Thickeners which are used in anionic surfactant-based shampoos are not suitable for the cationic shampoos according to the invention since they do not have a stable thickening effect in them.
  • hydroxypropyl guar derivatives and / or hydroxyethyl ethylcellulose derivatives which are used in the detergents in an amount of 0.1 to 3 wt .-%, preferably in an amount of 0.3 to 2 wt .-% become.
  • Particularly suitable thickening agents according to the invention are the hydroxypropyl guar derivatives sold under the trade names Jaguar HP-8, Jaguar HP-60, Jaguar HP-105, Jaguar HP-120, Jaguar HP-200, N-Hance HP-40, N-Hance HP-40S and the hydroxyethyl ethylcellulose derivatives commercially available under the names Elfacos CD-481 and Elfacos CDHM.
  • the cleaning agents further contain, based on their weight, from 0.05 to 3% by weight and in particular from 0.1 to 2% by weight of a further cationic surfactant selected from alkyltrimethylammonium chlorides or methosulfates, Dialkyldimethylammonium chlorides or methosulfates and / or trialkyl methylammonium chlorides or methosulfates having an alkyl chain length of 16 to 22 carbon atoms.
  • Particularly preferred cationic surfactants of this group according to the invention are betrentronium chloride and cetrimonium methosulfate.
  • the detergents according to the invention contain, based on their weight, from 0.05 to 2% by weight and in particular from 0.1 to 1% by weight of one or more styling polymers. These are preferably selected from the group Polyquaternium-55, Polyquaternium-46, Polyquaternium-11 and / or Polyquaternium-28.
  • detergents which, based on their weight, furthermore contain 0.05 to 3% by weight and in particular 0.1 to 2% by weight of a water-soluble or water-insoluble, volatile or nonvolatile silicone component.
  • detergents according to the invention which contain at least one silicone selected from:
  • polyalkyl siloxanes polyaryl siloxanes, polyalkylaryl siloxanes which are volatile or nonvolatile, straight chain, branched or cyclic, crosslinked or uncrosslinked;
  • grafted silicone polymers having a non-silicone organic backbone consisting of an organic backbone formed from organic monomers containing no silicone grafted with at least one polysiloxane macromer in the chain and optionally at least one chain end;
  • grafted polysiloxane backbone silicone polymers having grafted thereto non-silicone organic monomers having a polysiloxane backbone to which at least one organic macromer has been grafted in the chain and optionally at least at one of its ends; Containing silicone;
  • the hair treatment agents preferred according to the invention contain a silicone of the above formula I. These silicones are designated according to the INCI nomenclature as DIMETICONE.
  • dimethicone at 20 0 C a viscosity of> 6,000 cSt, preferably having such> cSt 20,000 and in particular> 40,000 cSt.
  • Particularly preferred agents according to the invention contain one or more amino-functional silicones.
  • Such silicones may e.g. through the formula
  • R is a hydrocarbon or a hydrocarbon radical having from 1 to about 6 carbon atoms
  • Q is a polar radical of the general formula -R 1 HZ, wherein R 1 is a divalent connecting group attached to hydrogen and the Z is an organic amino-functional moiety containing at least one amino-functional group
  • "a” assumes values in the range of about 0 to about 2
  • "b” assumes values in the range of about 1 to about 3
  • "a” + "b” is less than or equal to 3
  • "c” is a number in the range from about 1 to about 3
  • x is a number ranging from I to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25
  • y is a number ranging from about 20 to about 10,000 , preferably from about 125 to about 10,000, and most preferably from
  • Non-limiting examples of the groups represented by R include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, as well as sulfur-containing radicals such as mercaptoethyl, mercaptopropyl
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, - CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, - OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CH 2 ) 3 CC (O) OCH 2 CH 2 - C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • Z is an organic, amino-functional radical containing at least one functional amino group.
  • a possible formula for Z is NH (CH 2 ) Z NH 2 , wherein z is 1 or more.
  • Another possible formula for Z is -NH (CH 2 ) Z (CH 2 ) zzNH, wherein both z and zz are independently 1 or more, this structure comprising diamino ring structures, such as piperazinyl.
  • Z is most preferably a --NHCH 2 CH 2 NH 2 radical.
  • Another possible formula for Z is - N (CH 2) Z (CH 2) H2 NX 2 or -NX 2 wherein each X of X 2 is independently selected from the group consisting of hydrogen and Al kyl weakness having 1 to 12 carbon atoms , and zz is 0.
  • Q is most preferably a polar, amine functional group of the formula -CH 2 CH 2 CH 2 NHCH 2 CH 2 NH 2 .
  • "a” assumes values in the range of about 0 to about 2
  • "b” assumes values in the range of about 2 to about 3
  • "a” + “b” is less than or equal to 3
  • the molar ratio of R 3 Q b SiO (4. a. b) / 2 units to the R 0 SiO (4. c) / 2 units is in the range from about 1: 2 to 1:65, preferably from about 1: 5 to about 1:65, and most preferably from about 1:15 to about 1:20.
  • the various variables can be used Substituents in the above Formula may be different for the various silicone components present in the silicone blend.
  • Preferred hair treatment compositions according to the invention are characterized in that they contain an amino-functional silicone of the formula (II)
  • G is -H, a phenyl group, -OH, -O-CH 3 , -CH 3 , -O-CH 2 CH 3 , -CH 2 CH 3 , -O-
  • a is a number between O and 3, in particular O;
  • b is a number between 0 and 1, in particular 1,
  • n and n are numbers whose sum (m + n) is between 1 and 2,000, preferably between 50 and 150, where n is preferably from 0 to 1999 and especially from 49 to 149 and m is preferably from 1 to 2000, in particular from 1 to 10,
  • R ' is a monovalent radical selected from O -QN (R ") - CH 2 -CH 2 -N (R") 2 o -QN (R ") 2 O -QN + (R") 3 A " o - QN + H (R ") 2 A " o -QN + H 2 (R ”) A " o -QN (R 1 O-CH 2 -CH 2 -N + R 11 H 2 A ' , where each Q is a chemical bond, -CH 2 -, -CH 2 -CH 2 -, -CH 2 CH 2 CH 2 -, -C (CH 3 J 2 -, - CH 2 CH 2 CH 2 CH 2 -, -CH 2 C ( CH 3 ) 2 -, -CH (CH 3 ) CH 2 CH 2 -,
  • R represents identical or different radicals from the group -H, -phenyl, -benzyl, -CH 2 -CH (CH 3 ) Ph, the C 1, 2 o-alkyl radicals, preferably -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , -CH (CH 3 ) 2 , -CH 2 CH 2 CH 2 H 3 , - CH 2 CH (CH 3 ) 2 , -CH (CH 3 ) CH 2 CH 3 , -C ( CHs) 3 , and A represents an anion, which is preferably selected from chloride, bromide, iodide or methosulfate.
  • Particularly preferred hair treatment compositions according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (IIa)
  • silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration.
  • n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150 , where the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.
  • silicones are referred to as amodimethicones according to the INCI declaration.
  • hair-treatment compositions according to the invention which contain an amino-functional silicone whose amine number is above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g ,
  • the amine number stands for the milliequivalents of amine per gram of the amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.
  • Hair treatment agents preferred according to the invention are characterized in that, based on their weight, they contain 0.01 to 10% by weight, preferably 0.1 to 8% by weight, particularly preferably 0.25 to 7.5% by weight and in particular 0, 5 to 5 wt.% Amino-functional silicone (s) included.
  • the INCI CYCLOMETHICONE designated cyclic dimethicones are inventively used with preference.
  • hair treatment compositions according to the invention are preferred, the at least one silicone of the formula III
  • x is a number from 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and in particular 0, 1, 2, 3, 4, 5 or 6 stands.
  • the silicones described above have a backbone composed of -Si-O-Si units. Of course, these Si-O-Si units may also be interrupted by carbon chains. Appropriate molecules are accessible by chain extension reactions and are preferably used in the form of silicone-in-water emulsions.
  • silicone-in-water emulsions which can be used according to the invention can be prepared by known processes, as disclosed, for example, in US Pat. No. 5,998,537 and EP 0 874 017 A1.
  • this preparation process comprises the emulsifying mixture of components, one of which contains at least one polysiloxane, the other of which contains at least one organosilicon material which reacts with the polysiloxane in a chain extension reaction, wherein at least one metal ion-containing catalyst for the chain extension reaction, at least one surfactant and Water are present.
  • the chain extension reaction may also include the reaction of an Si-OH group (e.g., a hydroxy-terminated polysiloxane) with an alkoxy group (e.g., alkoxysilanes, silicates, or alkoxysiloxanes) in the presence of a metal-containing catalyst to form polysiloxanes.
  • an Si-OH group e.g., a hydroxy-terminated polysiloxane
  • an alkoxy group e.g., alkoxysilanes, silicates, or alkoxysiloxanes
  • the polysiloxanes used in the chain extension reaction include a ss-linear polymer of the following structure:
  • each R independently represents a hydrocarbon radical having up to 20 carbon atoms, preferably having 1 to 6 carbon atoms, such as an alkyl group (for example, methyl, ethyl, propyl or butyl), an aryl group (for example, phenyl), or group required for the chain extension reaction ("reactive group", for example Si-bonded H atoms, aliphatically unsaturated groups such as vinyl, allyl or hexenyl, hydroxy, alkoxy, such as methoxy, ethoxy or propoxy, alkoxy-alkoxy, acetoxy, amino, etc.), with the proviso that on average one to two reactive groups are present per polymer, n is a positive number> 1.
  • n is numbers which describe polysiloxanes, which viscosities between 1 and 1,000,000 mm z / s have, more preferably viscosities between 1,000 and 100,000 mm 2 / s.
  • the polysiloxanes may be branched to a low degree (for example, ⁇ 2 mol% of the siloxane units), but the polymers are substantially linear, more preferably fully linear.
  • the substituents R may in turn be substituted, for example with N-containing groups (for example amino groups), epoxy groups, S-containing groups, Si-containing groups, O-containing groups, etc.
  • N-containing groups for example amino groups
  • epoxy groups for example amino groups
  • S-containing groups for example amino groups
  • Si-containing groups for example O-containing groups
  • O-containing groups etc.
  • at least 80% of the radicals R are alkyl radicals, especially preferably methyl groups.
  • the organosilicone material that reacts with the polysiloxane in the chain extension reaction may be either a second polysiloxane or a molecule that acts as a chain extender.
  • the organosilicone material is a polysiloxane, it has the above-mentioned general structure. In these cases, one polysiloxane in the reaction has (at least) one reactive group, and a second polysiloxane has (at least) a second reactive group that reacts with the first.
  • the organosilicone material comprises a chain-extending agent
  • it may be a material such as a silane, a siloxane (e.g. disiloxane or trisiloxane) or a silazane.
  • a composition comprising a polysiloxane according to the above-described general structure having at least one Si-OH group can be chain extended by reacting with an alkoxysilane (for example, a dialkoxysilane or trialkoxysilane) in the presence of tin or titanium-containing catalysts is reacted.
  • an alkoxysilane for example, a dialkoxysilane or trialkoxysilane
  • the metal-containing catalysts in the chain extension reaction are usually specific for a particular reaction.
  • Such catalysts are known in the art and include, for example, metals such as platinum, rhodium, tin, titanium, copper, lead, etc.
  • a polysiloxane having at least one aliphatically unsaturated group, preferably an end group is reacted with an organosilicone material
  • a hydrosysylation catalyst which is a siloxane or polysiloxane having at least one (preferably terminal) Si-H group.
  • the polysiloxane has at least one aliphatically unsaturated group and satisfies the general formula given above in which R and n are as defined above, with an average of between 1 and 2 groups R having one aliphatic unsaturated group per polymer.
  • the organosilicone material having at least one Si-H group preferably has the above-mentioned structure, wherein R and n are as defined above and wherein, on average, between 1 and 2 groups R is hydrogen and n is 0 or a positive integer
  • This material may be a polymer or a low molecular weight material such as a siloxane (for example, a disiloxane or a trisiloxane).
  • the polysiloxane having at least one aliphatically unsaturated group and the organosilicon material having at least one Si-H group react in the presence of a hydrosilylation catalyst.
  • a hydrosilylation catalyst include, for example, platinum and rhodium-containing materials.
  • the catalysts may take any known form, for example platinum or rhodium coated on support materials (such as silica gel or activated carbon) or other suitable compounds such as platinum chloride, salts of platinum or chloroplatinic acids.
  • Chloroplatinic acid either as a commercially available hexahydrate or in anhydrous form, is a preferred catalyst because of its good dispersibility in organosilicone systems and low color changes.
  • a polysiloxane having at least one Si-OH group, preferably an end group is reacted with an organosilicone material having at least one alkoxy group, preferably a siloxane having at least one Si-OR group or an alkoxysilane having at least two alkoxy groups ,
  • the catalyst used is again a metal-containing catalyst.
  • organometallic compounds such as organotin salts, titanates or titanium chelates or complexes.
  • organometallic compounds such as organotin salts, titanates or titanium chelates or complexes.
  • organometallic compounds such as organotin salts, titanates or titanium chelates or complexes.
  • organometallic compounds such as organotin salts, titanates or titanium chelates or complexes.
  • organometallic compounds such as organotin salts, titanates or titanium chelates or complexes.
  • organometallic compounds such as organotin salts, titanates or titanium chelates or complexes.
  • examples include stannous octoate, dibutyltin dilaurate, dibutyltin diacetate, dimethyltin dineodecanoate, dibutyltin dimethoxide, isobutyltin triceroate, dimethyltin dibutyrate, dimethyltin dineo
  • silicone-in-water emulsions preferably contain at least one surfactant.
  • R 3 is -Si- [O-SiR 2 ] x - (CH 2 ) n - [O-SiR 2 ] y -O-SiR 3 (IV),
  • R is identical or different radicals from the group -H, -phenyl, -benzyl, -CH 2 -CH (CH 3 ) Ph, the C ⁇ o-alkyl radicals, preferably -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , -CH (CH 3 ) 2 , -CH 2 CH 2 CH 2 CH 3 , -CH 2 CH (CHa) 2 , -CH (CH 3 ) CH 2 CH 3 , -C ( CH 3 ) 3 , x and y are a number from 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and in particular 0, 1, 2, 3, 4, 5 or 6, and n is a number from 0 to 10, preferably from 1 to 8 and in particular from 2, 3, 4, 5, 6.
  • the silicones of the cleaning agents according to the invention are insoluble in water. Hair treatment compositions which are preferred according to the invention are therefore characterized in that they can additionally contain a water-soluble silicone
  • the shampoos according to the invention may further contain vitamins, protein hydrolysates, polyols, cationic and / or nonionic polymers, plant extracts, pearlescing agents, opacifiers, perfume components, pH adjusters, colorants, preservatives, optionally fatty substances and other viscosity adjusting components.
  • Suitable pearlescing waxes are, for example: alkylene glycol esters; fatty acid; partial glycerides; Esters of polybasic, optionally hydroxy-substituted carboxylic acids with fatty alcohols having 6 to 22 carbon atoms; Fatty substances, such as, for example, fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates, which in total have at least 24 carbon atoms; Ring opening products of olefin epoxides having 12 to 22 carbon atoms with fatty alcohols having 12 to 22 carbon atoms and / or polyols having 2 to 15 carbon atoms and 2 to 10 hydroxyl groups and mixtures thereof.
  • fatty substances can furthermore be contained.
  • Fatty substances are to be understood as meaning fatty acids, fatty alcohols, natural and synthetic waxes, which can be in solid form as well as liquid in aqueous dispersion, and natural and synthetic cosmetic oil components.
  • the fatty acids used can be linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids having 10 to 22 carbon atoms. Among these were, for example, to name the isostearic as the commercial products Emersol ® 871 and Emersol ® 875, and isopalmitic acids such as the commercial product Edenor ® IP 95, and all other products sold under the trade names Edenor ® (Cognis) fatty acids.
  • fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic and erucic acid and their technical mixtures, which are obtained, for example, in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from Roelen's oxo synthesis or the dimerization of unsaturated fatty acids.
  • the fatty acid cuttings obtainable from coconut oil or palm oil;
  • the use of stearic acid is usually preferred.
  • the amount used is 0.1 - 15 wt.%, Based on the total mean. In a preferred embodiment, the amount is 0.5-10% by weight, very particularly preferably amounts of 1-5% by weight.
  • fatty alcohols it is possible to use saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C 6 -C 30 -, preferably C w -C 2 ⁇ - and very particularly preferably C 12 -C 2 2- carbon atoms.
  • the fatty alcohols are derived from preferably natural fatty acids, which can usually be based on recovery from the esters of fatty acids by reduction.
  • those fatty alcohol cuts which are produced by reducing naturally occurring triglycerides such as beef tallow, palm oil, peanut oil, rapeseed oil, cottonseed oil, soybean oil, sunflower oil and linseed oil or fatty acid esters formed from their transesterification products with corresponding alcohols, and thus represent a mixture of different fatty alcohols.
  • Such substances are, for example, under the names Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®, for example, Lorol ® C8, Lorol C14 ®, Lorol C18 ®, ® Lorol C8-18, HD-Ocenol ®, Crodacol ® such as Crodacol ® CS, Novol ®, Eutanol ® G, Guerbitol ® 16, Guerbitol ® 18, Guerbitol ® 20, Isofol ® 12, Isofol ® 16, Isofol ® 24, Isofol ® 36, Isocarb ® 12, Isocarb ® 16 or Isocarb® ® 24 available for purchase.
  • Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®
  • Lorol ® C8 Lorol C8-18
  • the invention also wool wax alcohols, as are commercially available, for example under the names of Corona ®, White Swan ®, Coronet ® or Fluilan ® can be used.
  • the fatty alcohols are used in amounts of from 0.1 to 20% by weight, based on the total preparation, preferably in amounts of from 0.1 to 10% by weight.
  • the natural or synthetic waxes used according to the invention are solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes of PE or PP.
  • Such waxes are available, for example, from Kahl & Co., Trittau.
  • the natural and synthetic cosmetic oil bodies which can increase the action of the active ingredient according to the invention include, for example: vegetable oils.
  • vegetable oils examples include sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil.
  • triglyceride oils such as the liquid portions of beef tallow as well as synthetic triglyceride oils.
  • Ester oils are to be understood as meaning the esters of C 6 - C 30 fatty acids with C 2 - C 30 fatty alcohols. The monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred.
  • fatty acid components used in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselic acid, linoleic acid, linolenic acid, elaeostearic acid, Arachidic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures, which are obtained, for example, in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from the Roelen oxo synthesis or the dimerization of unsaturated fatty acids.
  • fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, Arachylalkohol, Gadoleylalkohol, Behe- nylalkohol, Erucylalkohol and Brassidylalkohol as well as their technical mixtures, which for example in the high-pressure hydrogenation of technical methyl esters based on fats and oils or aldehydes from the Roelen oxo synthesis and as a monomer fraction in the dimerization of unsaturated fatty alcohol
  • Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate
  • diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2- ethylhexanoate), propylene glycol diisostearate, propylene glycol di-pelargonat, butanediol di-isostearate, Neopentylglykoldicaprylat, symmetrical, asymmetric or cyclic esters of carbonic acid with fatty alcohols, for example described in DE-OS 197 56 454, glycerol carbonate or dicaprylyl (Cetiol ® CC), Mono, - di- and trifatty acid esters of saturated and / or unsaturated linear and / or
  • the amount used is 0.01-50% by weight, based on the total agent, preferably 0.1-10% by weight and more preferably 0.1-5% by weight, based on the total agent.
  • the total amount of the oil and fat components in the inventive compositions 0.01 -5 wt .-%, based on the total agent. Amounts of 0.1-0.5 wt% are preferred.
  • the shampoos may further contain polyols.
  • Polyols which are suitable for the purposes of the invention preferably have 2 to 15 carbon atoms and at least two hydroxyl groups. Typical examples are
  • Alkylene glycols such as ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol, and polyethylene glycols having an average molecular weight of 100 to 1,000 daltons;
  • MethyolENSen in particular trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;
  • Lower alkyl glucosides in particular those having 1 to 8 carbons in the alkyl radical, such as, for example, methyl and butyl glucoside;
  • Sugar alcohols having 5 to 12 carbon atoms such as sorbitol or mannitol,
  • sugars having 5 to 12 carbon atoms such as glucose or sucrose
  • compositions comprising a mixture of a plurality of polyols. Particular preference is given to a mixture of glycerol, sorbitol, 1,2-propylene glycol and polyethylene glycol.
  • the polyol mixture is used in the shampoos preferably in amounts of 0.1 to 35 wt .-%, more preferably an amount used in the range of 1 to 20 wt .-%.
  • the agents according to the invention may contain protein hydrolyzates and / or amino acids and their derivatives (H).
  • Protein hydrolysates are product mixtures characterized by acidic, or enzymatically catalyzed degradation of proteins (proteins) are obtained.
  • protein hydrolyzates also means total hydrolyzates as well as individual amino acids and their derivatives as well as mixtures of different amino acids.
  • polymers made up of amino acids and amino acid derivatives are understood by the term protein hydrolyzates. The latter include, for example, polyalanine, polyasparagine, polyserine, etc.
  • Examples of compounds which can be used according to the invention are L-alanyl-L-pro-yne, polyglycine, glycyl-L-glutamine or D / L-methionine-S-methylsulfonium chloride.
  • ⁇ -amino acids and their derivatives such as ⁇ -alanine, anthranilic acid or hippuric acid can also be used.
  • the molecular weight of the protein hydrolysates which can be used according to the invention is between 75, the molecular weight for glycine, and 200,000, preferably the molecular weight is 75 to 50,000 and very particularly preferably 75 to 20,000 daltons.
  • protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein hydrolysates, which may also be present in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois® ® (Interorgana) Collapuron ® (Cognis), Nutrilan® ® (Cognis), Gelita-Sol ® (German Gelatinefabriken Stoess & Co), Lexein ® (ino- lex ) and kerasol tm ® (Croda) sold.
  • Preferred according to the invention is the use of protein hydrolysates of plant origin, eg. Soybean, almond, pea, potato and wheat protein hydrolysates.
  • Such products are, for example, under the trademark Gluadin ® (Cognis), diamine ® (Diamalt) ® (Inolex), Hydrosoy ® (Croda), hydro Lupine ® (Croda), hydro Sesame ® (Croda), Hydro tritium ® (Croda), and Cro ton ® (Croda) available.
  • protein hydrolysates Although the use of the protein hydrolysates is preferred as such, amino acid mixtures otherwise obtained may be used in their place, if appropriate. Also possible is the use of derivatives of protein hydrolysates, for example in the form of their fatty acid condensation products. Such products are sold for example under the names Lamepon® ® (Cognis), Lexein ® (Inolex), Crolastin ® (Croda) or crotein ® (Croda).
  • the protein hydrolysates or their derivatives are preferably contained in the preparations used according to the invention in amounts of from 0.1 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred. Also advantageous has proved the use of vitamins, provitamins and vitamin precursors and their derivatives in the compositions of the invention. According to the invention, such vitamins, pro-vitamins and vitamin precursors are preferred, which are usually assigned to groups A, B, C, E, F and H.
  • vitamin A includes retinol (vitamin Ai) and 3,4-didehydroretinol (vitamin A 2 ).
  • the ß-carotene is the provitamin of retinol.
  • vitamin A component according to the invention for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration.
  • the preparations used according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.
  • the vitamin B group or the vitamin B complex include vitamin B 1 (thiamine) vitamin B 2 (riboflavin)
  • Vitamin B 3 the compounds nicotinic acid and nicotinamide (niacinamide) are often performed.
  • Preferred according to the invention is the nicotinic acid amide, which is preferably contained in the agents according to the invention in amounts of from 0.05 to 1% by weight, based on the total agent.
  • Vitamin B 5 pantothenic acid, panthenol and pantolactone.
  • Panthenol and / or pantolactone are preferably used in the context of this group.
  • Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically dehvated panthenols. Individual representatives are, for example, the panthenol triacetate, the panthenol monoethyl ether and its monoacetate and also the cationic panthenol derivatives disclosed in WO 92/13829.
  • the said compounds of the vitamin B 5 type are preferably contained in the agents used according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred. Vitamin B 6 (pyridoxine and pyridoxamine and pyridoxal).
  • Vitamin C (ascorbic acid). Vitamin C is used in the compositions according to the invention preferably in amounts of 0.1 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.
  • Vitamin E tocopherols, especially ⁇ -tocopherol.
  • Tocopherol and its derivatives which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents used according to the invention in amounts of 0.05-1% by weight, based on the total agent , Vitamin F.
  • Vitamin F is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
  • Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-c (imidazole-4-valeric acid], for which the trivial name biotin has meanwhile become established the agents used according to the invention preferably in amounts of 0.0001 to 1, 0 wt .-%, in particular in amounts of 0.001 to 0.01 wt .-%.
  • the preparations according to the invention preferably contain vitamins, provitamins and vitamin precursors from groups A, B, E and H. Of course, several vitamins and vitamin precursors may also be present at the same time.
  • Panthenol, pantolactone, pyridoxine and its derivatives as well as nicotinic acid amide and biotin are particularly preferred.
  • the amount of vitamins and vitamin precursors used in the compositions according to the invention is 0.0001-10% by weight, based on the total agent, preferably 0.0001-5% by weight, and in particular 0.0001-3% by weight.
  • plant extracts can be used in the compositions according to the invention. Usually these extracts are produced by extraction of the whole plant. However, in individual cases it may also be preferred to prepare the extracts exclusively from flowers and / or leaves of the plant.
  • extracts of green tea, almond, aloe vera, coconut, mango, apricot, lime, wheat, kiwi and melon are especially suitable for the use according to the invention.
  • alcohols and mixtures thereof can be used as extraction agent for the preparation of said plant extracts water.
  • the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as ethylene glycol and propylene glycol, both as sole extractant and in admixture with water, are preferred.
  • Plant extracts based on water / propylene glycol in a ratio of 1:10 to 10: 1 have proven to be particularly suitable.
  • the plant extracts can be used according to the invention both in pure and in diluted form. If they are used in diluted form, they usually contain about 2 to 80 wt .-% of active substance and as a solvent used in their extraction agent or extractant mixture.
  • compositions according to the invention mixtures of several, especially two, different plant extracts.
  • the amount used of the plant extracts in the compositions according to the invention is usually 0.01-50% by weight, based on the total agent, preferably 0.1-30% by weight, and in particular 0.1-20% by weight.
  • Preferred cationic polymers within the meaning of the invention are sederivate example, cationic CeIIuIo-, such as a quaternized hydroxyethyl cellulose obtainable from Amerchol under the name Polymer JR ® 400, cationic starch, copolymers of diallyl ammonium salts and acrylamides, quaternized vinyl pyrrolidone / vinyl imidazole polymers such as Luviquat ® (BASF), condensation products of polyglycols and amines, quaternized collagen polypeptides, for example lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat® ® L / Grunau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers, for example, amodimethicone, copolymers of adipic acid and dimethylaminohydroxypropyl ( Cartareti- ne ® / Sandoz), copolymers of acryl
  • Suitable nonionic polymers are, for example:
  • Vinylpyrrolidone / Vinylester copolymers as are marketed, for example under the trademark Lu viskol ® (BASF).
  • Luviskol ® VA 64 and Luviskol ® VA 73, each vinylpyrrolidone / vinyl acetate copolymers are also preferred nonionic polymers.
  • Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and methylhydroxypropyl cellulose, such as are for example sold under the trademark Culminal® ® and Benecel ® (Aqualon). shellac
  • Siloxanes These siloxanes can be both water-soluble and water-insoluble. Both volatile and nonvolatile siloxanes are suitable, nonvolatile siloxanes being understood as meaning those compounds whose boiling point is above 200 ° C. under normal pressure.
  • Preferred siloxanes are polydialkylsiloxanes, such as, for example, polydimethylsiloxane, polyalkylarylsiloxanes, such as, for example, polyphenylmethylsiloxane, ethoxylated polydialkylsiloxanes and polydialkylsiloxanes which contain amine and / or hydroxyl groups. Glycosidically substituted silicones according to EP 0612759 B1.
  • the polymers are preferably contained in the agents used according to the invention in amounts of from 0.01 to 10% by weight, based on the total agent. Amounts of 0.1 to 5, in particular from 0.1 to 3 wt .-%, are particularly preferred.
  • short-chain carboxylic acids may additionally be used.
  • Short-chain carboxylic acids and their derivatives in the context of the invention are understood to mean carboxylic acids which may be saturated or unsaturated and / or straight-chain or branched or cyclic and / or aromatic and / or heterocyclic and have a molecular weight of less than 750.
  • preference may be given to saturated or unsaturated straight-chain or branched carboxylic acids having a chain length of from 1 to 16 C atoms in the chain, very particular preference being given to those having a chain length of from 1 to 12 C atoms in the chain ,
  • the short-chain carboxylic acids according to the invention may have one, two, three or more carboyl groups.
  • Preferred within the meaning of the invention are carboxylic acids having a plurality of carboxyl groups, in particular di- and tricarboxylic acids.
  • the carboxy groups can be used, in whole or in part, as ester, acid anhydride, lactone, amide, imidic acid, lactam, lactim, dicarboximide, carbohydrate zid, hydrazone, hydroxam, hydroxime, amidine, amidoxime, nitrile, phosphonic or phosphate ester.
  • the carboxylic acids according to the invention may of course be substituted along the carbon chain or the ring skeleton.
  • the substituents of the carboxylic acids according to the invention include, for example, C 1 -C 8 -alkyl, C 2 -C 8 -alkenyl, aryl, aralkyl and aralkynyl, hydroxymethyl, C 2 -C 8 -hydroxyalkyl, C 2 -C 8 -hydroxyalkenyl , Aminomethyl, C2-C8-aminoalkyl, cyano, formyl, oxo, thioxo, hydroxy, mercapto, amino, carboxy or imino groups.
  • Preferred substituents are C 1 -C 8 alkyl, hydroxymethyl, hydroxy, amino and carboxy groups. Particularly preferred are substituents in ⁇ - position.
  • substituents are hydroxy, alkoxy and amino groups, where the amino function may optionally be further substituted by alkyl, aryl, aralkyl and / or alkenyl radicals.
  • preferred carboxylic acid derivatives are the phosphonic and phosphate esters.
  • carboxylic acids examples include formic acid, acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, pivalic acid, oxalic acid, malonic acid, succinic acid, glutaric acid, glyceric acid, glyoxylic acid, adipic acid, pimelic acid, suberic acid, sebacic acid, propiolic acid, crotonic acid, isocrotonic acid , elaidic acid, maleic acid, fumaric acid, muconic acid, citraconic acid, mesaconic acid, camphoric acid, benzoic acid, o, m, p-phthalic acid, naphthoic acid, Toluoylklare, hydratropic acid, atropic acid, cinnamic acid, isonicotinic acid, nicotinic acid, Bicarbaminklare, 4,4 '-Dicyano-6, 6
  • n is a number from 4 to 12 and one of the two groups X and Y is a COOH group and the other is hydrogen or a methyl or Ethyl radical
  • dicarboxylic acids of the general formula (NI) which additionally carry 1 to 3 methyl or ethyl substituents on Cyclohe- xenring and dicarboxylic acids formed from the dicarboxylic acids according to formula (NI) formally by addition of a molecule of water to the double bond in the cyclohexene ring.
  • the dicarboxylic acids of the formula (NI) can be prepared, for example, by reacting polyunsaturated dicarboxylic acids with unsaturated monocarboxylic acids in the form of a Diels-Alder cyclization. Usually one will assume a polyunsaturated fatty acid as the dicarboxylic acid component. Preferred is the linoleic acid obtainable from natural fats and oils. Acrylic acid, but also, for example, methacrylic acid and crotonic acid are particularly preferred as the monocarboxylic acid component. Normally, in the case of reactions according to Diels-Alder, mixtures of isomers are formed in which one component is present in excess. These isomer mixtures can be used according to the invention as well as the pure compounds.
  • those dicarboxylic acids which differ from the compounds according to formula (NI) by 1 to 3 methyl or ethyl substituents on the cyclohexyl ring or formally from these compounds by addition of one molecule of water are also usable according to the invention be formed on the double formation of the cyclohexene ring.
  • the dicarboxylic acid (mixture) which has been obtained by reacting linoleic acid with acrylic acid has proved to be particularly advantageous according to the invention. It is a mixture of 5- and 6-carboxy-4-hexyl-2-cyclohexene-1-octanoic acid.
  • Such compounds are commercially available under the designations Westvaco Diacid 1550 Westvaco Diacid ® ® 1595 (manufacturer: Westvaco).
  • carboxylic acids of the invention listed above by way of example, their physiologically tolerable salts can also be used according to the invention.
  • examples of such salts are the alkali metal salts, alkaline earth metal salts, zinc salts and ammonium salts, which in the context of the present application also includes the mono-, di- and trimethyl-, -ethyl- and -hydroxyethyl ammonium salts.
  • neutralized acids can very particularly preferably be used with alkaline-reacting amino acids, such as, for example, arginine, lysine, ornithine and histidine.
  • hydroxycarboxylic acids and here again in particular the dihydroxy-, trihydroxy- and polyhydroxycarboxylic acids as well as the dihydroxy, trihydroxy and polyhydroxy di-, tri- and polycarboxylic acids. It has been found that, in addition to the hydroxycarboxylic acids, the hydroxycarboxylic acid esters and the mixtures of hydroxycarboxylic acids and their esters as well as polymeric hydroxycarboxylic acids and their esters can be very particularly preferred.
  • Preferred hydroxycarboxylic acid esters are, for example, full esters of glycolic acid, lactic acid, malic acid, tartaric acid or citric acid.
  • hydroxycarboxylic acid esters are esters of ⁇ -hydroxypropionic acid, the tartrone acid, D-gluconic acid, sugar acid, mucic acid or glucuronic acid.
  • Suitable alcohol components of these esters are primary, linear or branched aliphatic alcohols having 8-22 C atoms, ie, for example, fatty alcohols or synthetic fatty alcohols.
  • the esters of C12-C15 fatty alcohols are particularly preferred.
  • Esters of this type are commercially available, eg under the trademark Cosmacol® ® EniChem, Augusta Industriale.
  • Particularly preferred polyhydroxypolycarboxylic acids are polylactic acid and polyuric acid and their esters.
  • compositions of the invention may further contain anionic polymers.
  • the homopolymer of 2-acrylamido-2-methyl propane sulfonic acid which is commercially available, for example under the name Rheothik ® 1 1-80 is.
  • copolymers of at least one anionic monomer and at least one nonionic monomer are preferable to use copolymers of at least one anionic monomer and at least one nonionic monomer.
  • anionic monomers reference is made to the substances listed above.
  • Preferred nonionic monomers are acrylamide, methacrylamide, acrylic esters, methacrylic esters, vinylpyrrolidone, vinyl ethers and vinyl esters.
  • Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers.
  • a particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group is wholly or partly as sodium, potassium, ammonium, mono or ' triethanolammonium Salt is present.
  • This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene-bisacrylamide are used.
  • crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene-bisacrylamide are used.
  • crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene-bisacrylamide are used.
  • Such a polymer is contained in the commercial product Sepigel ® 305 from SEPPIC.
  • Simulgel ® 600 as a compound with isohexadecane and polysorbate-80 Natriumacryloyldimethyltaurat copolymers have proved to be particularly effective according to the invention.
  • anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ® commercially. Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-retaining polymers. A 1, 9-decadiene crosslinked maleic acid methyl vinyl ether copolymer is available under the name Stabileze® ® QM.
  • the other active ingredients, auxiliaries and additives which are used in minor amounts in the preferred embodiments are, for example, further thickeners such as agar-agar, guar gum, alginates, xanthan gum, gum arabicum, karaya gum, locust bean gum , Linseed gums, dextrans, cellulose derivatives, e.g. As methylcellulose, hydroxyalkylcellulose and carboxymethylcellulose, starch fractions and derivatives such as amylose, amylopectin and dextrins, clays such. As bentonite or fully synthetic hydrocolloids such.
  • hair conditioning compounds such as phospholipids, for example, soybean lecithin, egg lecithin and cephalins, and silicone oils, perfume oils, dimethyl isosorbide and cyclodextrins,
  • Solvents and mediators such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerol and diethylene glycol, fiber structure-improving agents, in particular mono-, di- and oligosaccharides such as glucose, galactose, fructose, fructose and lactose, conditioning agents such as paraffin oils, vegetable oils, eg , As sunflower oil, orange oil, almond oil, wheat germ oil and peach kernel oil and quaternized amines such as methyl-1-alkylamidoethyl-2-alkylimidazolinium methosulfate, defoamers such as silicones, dyes for staining the agent,
  • Antidandruff active ingredients such as Piroctone Olamine, Zinc Omadine and Climbazole, active ingredients such as. Allantoin and bisabolol, cholesterol, thickeners like Zuckerester, polyol esters or polyol, fats and waxes, such as spermaceti, beeswax, montan wax and paraffins, fatty acid '
  • Complexing agents such as EDTA, NTA, ⁇ -alaninediacetic acid and phosphonic acids, swelling and penetrating agents such as primary, secondary and tertiary phosphates, opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers, pearlescing agents such as ethylene glycol mono- and distearate and PEG-3 distearate, pigments,
  • Propellants such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air, antioxidants, pH regulators such as citric acid or lactic acid, preservatives such as benzoic acid or salicylic acid.
  • pH regulators such as citric acid or lactic acid
  • preservatives such as benzoic acid or salicylic acid.
  • a second aspect of the invention is the use of a substantially anionic surfactant-free detergent containing from 1 to 50% by weight of a cationic surfactant of the formula (I)
  • R is an alkyl group having 8 to 18 C atoms, preferably an alkyl group having 8 to 16 C atoms and in particular an alkyl group having 10 to 14 C atoms
  • R 1 , R 2 , R 3 are each independently one C 1 -C 3 -alkyl group and X " stands for halogen or methosulfate, for the conditioning of the hair.
  • a third object of the invention is the use of the cleaning agent according to the invention for color protection of the hair.
  • a fourth object of the invention is the use of the cleaning agent according to the invention for the reduction and prevention of hair damage.
  • the following shampoos were prepared according to the invention.
  • the quantities are based on wt .-%.
  • Cocotrimonium Methosulfate (30% AS) 35.0 Cocamide MEA 2.5 Cocamidopropyl Betaine (30% AS) 5.0 Hydroxypropyl Guar ( Jaguar® HP-200) 1.0 Polyethyleneimine 0.3 Lactic Acid qs Perfume 0.3 Water ad 100
  • Cocotrimonium Methosulfate (30% AS) 35.0 Cocamide MEA 2.5 Cocamidopropyl Betaine (30% AS) 5.0 Hydroxypropyl guar ( Jaguar® HP-40) 1, 0
  • Cocotrimonium Methosulfate (30% AS) 35.0 Cocamide MEA 2.5
  • Cocamidopropyl Betaine (30% AS) 5.0 Hydroxypropyl Guar (Jaguar ® HP-60) 1 0 Behentrimonium Chloride 1 0 0 Lactic Acid qs perfume, 3 water ad 100
  • Cocotrimonium Methosulfate (30% AS) 35.0 Cocamide MEA 2.5 Cocamidopropyl Betaine (30% AS) 5.0 Hydroxypropyl Guar (Jaguar ® HP-60) 0.5 hydroxyethyl ethylcellulose 0.5 Lactic Acid qs Perfume 0, 3 water ad 100

Abstract

La présente invention concerne un agent de lavage sensiblement dépourvu de tensioactif anionique, destiné à des fibres de kératine, et contenant - rapportés à son poids - 1 à 50 % en poids d'un ou de plusieurs tensioactifs cationiques de formule (I) dans laquelle: R est groupe alkyle comprenant de 8 à 18 atomes de C; R<SUP>1</SUP>, R<SUP>2</SUP> et R<SUP>3</SUP> représentent indépendamment un groupe alkyle en C<SUB>1</SUB>-C<SUB>3</SUB>; et X est halogène ou méthosulfate.
EP06701092A 2005-02-17 2006-01-26 Compositions de shampooing a base de tensioactifs cationiques Ceased EP1865910A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65373205P 2005-02-17 2005-02-17
PCT/EP2006/000668 WO2006087078A1 (fr) 2005-02-17 2006-01-26 Compositions de shampooing a base de tensioactifs cationiques

Publications (1)

Publication Number Publication Date
EP1865910A1 true EP1865910A1 (fr) 2007-12-19

Family

ID=36091951

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06701092A Ceased EP1865910A1 (fr) 2005-02-17 2006-01-26 Compositions de shampooing a base de tensioactifs cationiques

Country Status (4)

Country Link
US (1) US20070060489A1 (fr)
EP (1) EP1865910A1 (fr)
RU (1) RU2007134258A (fr)
WO (1) WO2006087078A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1975224A1 (fr) * 2007-03-30 2008-10-01 Johnson & Johnson Consumer France SAS Composition de nettoyage moussante, et douce
DE102008038137A1 (de) * 2008-08-18 2010-02-25 Henkel Ag & Co. Kgaa Sulfatfreies mildes Tensidsystem zur Haut- und Haarreinigung
BRPI0918972A2 (pt) * 2008-08-28 2015-12-01 Procter & Gamble composições para tratamento de tecidos, processo de fabricação, e método de uso
US20100050346A1 (en) * 2008-08-28 2010-03-04 Corona Iii Alessandro Compositions and methods for providing a benefit
EP2512423B1 (fr) * 2009-12-18 2018-12-12 L'Oréal Procédé de traitement de fibres de kératine
DE102009055357A1 (de) * 2009-12-29 2011-06-30 Henkel AG & Co. KGaA, 40589 Mittel für keratinhaltige Fasern, enthaltend mindestens ein spezielles amphiphiles kationisches Polymer und mindestens ein spezielles kationisches Polymer mit Vinylimidazolstruktureinheiten
WO2011124560A2 (fr) * 2010-04-09 2011-10-13 Dsm Ip Assets B.V. Compositions de soin capillaire
BR112013001852A2 (pt) * 2010-08-20 2016-05-31 Unilever Nv composição para condicionamento dos cabelos que compreende um tensoativo catiônico e uma mistura de óleos
BR112014029766A2 (pt) * 2012-05-30 2017-06-27 Clariant Finance Bvi Ltd composições contendo álcoois graxos, tensoativos catiônicos e n-acil-n-metilglucaminas
BR112014029758A2 (pt) 2012-05-30 2017-06-27 Clariant Finance Bvi Ltd composição contendo n-metil-n-acilglucamina
JP6454270B2 (ja) 2012-05-30 2019-01-16 クラリアント・ファイナンス・(ビーブイアイ)・リミテッド 可溶化剤としてのn−メチル−n−アシルグルカミンの使用
DE102012216294A1 (de) * 2012-09-13 2014-03-13 Henkel Ag & Co. Kgaa Haarpflegemittel mit ausgewählten aminofunktionalen Silikonen und ausgewählten kationischen Tensiden auf pflanzlicher Basis
DE102012021647A1 (de) 2012-11-03 2014-05-08 Clariant International Ltd. Wässrige Adjuvant-Zusammensetzungen
DE102014005771A1 (de) 2014-04-23 2015-10-29 Clariant International Ltd. Verwendung von wässrigen driftreduzierenden Zusammensetzungen
FR3029110B1 (fr) * 2014-11-27 2018-03-09 L'oreal Composition cosmetique comprenant un organosilane, un tensioactif cationique et un polymere cationique ayant une densite de charge superieure ou egale a 4 meq/g
US20190008750A1 (en) * 2015-08-14 2019-01-10 L'oreal Cosmetic composition comprising a cationic surfactant, a fatty alcohol, an amphoteric surfactant, a starch derivative, and a cationic conditioning polymer
DE102015219651A1 (de) 2015-10-09 2017-04-13 Clariant International Ltd. Zusammensetzungen enthaltend Zuckeramin und Fettsäure
DE102015219608B4 (de) 2015-10-09 2018-05-03 Clariant International Ltd Universelle Pigmentdispersionen auf Basis von N-Alkylglukaminen
FR3044904B1 (fr) 2015-12-14 2019-05-31 L'oreal Composition comprenant l'association d'alcoxysilanes particuliers et d'un tensioactif
DE202016003070U1 (de) 2016-05-09 2016-06-07 Clariant International Ltd. Stabilisatoren für Silikatfarben
DE102016218984A1 (de) * 2016-09-30 2018-04-05 Henkel Ag & Co. Kgaa "verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz"

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4534877A (en) * 1982-07-30 1985-08-13 The Procter & Gamble Company Shampoo compositions comprising specific betaine surfactants and a quaternary compound
GB8724254D0 (en) * 1987-10-15 1987-11-18 Unilever Plc Hair treatment product
FR2666346B1 (fr) * 1990-09-05 1992-11-20 Oreal Composition de lavage et/ou de traitement cosmetique avec rincage des fibres keratiniques, a sechage rapide, a base de composes cationiques fluores et d'alkylpolyglycosides.
US5693317A (en) * 1991-09-30 1997-12-02 Colgate-Palmolive Company Conditioning rinse compositions which facilitates setting of hair
DE4227203C2 (de) * 1992-08-17 1994-03-24 Kao Corp Gmbh Mittel und Verfahren zur Haarbehandlung
DE19606545A1 (de) * 1996-02-22 1997-08-28 Wella Ag Kosmetisches Mittel mit einem Gehalt an Ilexharz, Verfahren zur Gewinnung von Ilexharz und durch dieses Verfahren erhältliches Ilexharz
DE19717925A1 (de) * 1997-04-28 1998-10-29 Basf Ag Wässrige kationische Tensidzubereitungen, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
BR9806128A (pt) * 1997-08-28 1999-08-31 Wella Ag Agente de cuidado de dois componentes
DE19836808A1 (de) * 1998-08-14 2000-02-24 Basf Ag Verdickungsmittel für tensidhaltige Zusammensetzungen
GB9909711D0 (en) * 1999-04-27 1999-06-23 Unilever Plc Mousse forming hair treatment composition
US6217889B1 (en) * 1999-08-02 2001-04-17 The Proctor & Gamble Company Personal care articles
DE19937386A1 (de) * 1999-08-07 2001-02-15 Wella Ag Volumengebendes Haarbehandlungsmittel
US6730292B1 (en) * 1999-09-03 2004-05-04 The Procter & Gamble Company Hair care composition comprising a polypropylene glycol and an ester oil
US6709648B2 (en) * 2000-05-30 2004-03-23 The Procter & Gamble Company Hair conditioning composition comprising silicones and frizz control agents
DE10041211A1 (de) * 2000-08-22 2002-03-07 Basf Ag Verwendung hydrophiler Pfropfcopolymere mit N-Vinylamin-und /oder offenkettigen n-Vinylamdeinheiten in kosmetischen Formulierungen
DE10245586A1 (de) * 2002-09-27 2004-04-08 Basf Ag Verwendung von Polymerisaten auf Basis von N-Vinylcaprolactam
EP1549282A1 (fr) * 2002-10-10 2005-07-06 The Procter & Gamble Company Composition apres-shampoing contenant un polymere epaississant et un agent de surface cationique
US7776813B2 (en) * 2004-09-15 2010-08-17 The Procter & Gamble Company Fabric care compositions comprising polyol based fabric care materials and deposition agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2006087078A1 *

Also Published As

Publication number Publication date
RU2007134258A (ru) 2009-03-27
US20070060489A1 (en) 2007-03-15
WO2006087078A1 (fr) 2006-08-24

Similar Documents

Publication Publication Date Title
EP1865910A1 (fr) Compositions de shampooing a base de tensioactifs cationiques
EP1714678B1 (fr) Composition de nettoyage à faible teneur en eau
DE602004012097T2 (de) Haar- oder haut-konditionierungszusammensetzung mit hydrophobisch modifiziertem kationisch verdickendem polymer
DE102015223820A1 (de) &#34;Leistungsstarke Haarbehandlungsmittel mit strukturstärkendem-Effekt&#34;
DE102015223829A1 (de) Leistungsstarke Haarbehandlungsmittel mit Anti-Auswasch-Effekt
EP2335671A2 (fr) Soin capillaire à une seule phase
DE102015223826A1 (de) Leistungsstarke Haarbehandlungsmittel mit strukturstärkendem Effekt
DE102011004123A1 (de) Kosmetisches Reinigungsmittel zur Erhöhung des Haarvolumens
DE102015223854A1 (de) Leistungsstarke Haarbehandlungsmittel mit strukturstärkendem Effekt
DE102016219005A1 (de) Verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz
EP1830798B1 (fr) Agents de traitement capillaire contenant des proteines ou polypeptides de corneocyte et des silicones
DE102015223831A1 (de) Leistungsstarke Haarbehandlungsmittel mit Anti-Auswasch-Effekt
DE102017215071A1 (de) Leistungsstarke Haarbehandlungsmittel mit gesteigerter Pflegewirkung
DE102016218984A1 (de) &#34;verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz&#34;
EP1871487A1 (fr) Composition d&#39;hygiene corporelle sous une forme nouvelle pour la cosmetique
DE102005052100A1 (de) Haarbehandlungsmittel mit verbesserter Pflegeleistung sowie Verfahren zur Applikation des Mittels
DE102017218984A1 (de) &#34;Strukturkräftigende Haarbehandlungsmittel mit gesteigerter Pflegewirkung &#34;
DE102017218980A1 (de) &#34;Strukturkräftigende Haarbehandlungsmittel mit gesteigerter Pflegewirkung &#34;
DE102016218999A1 (de) Verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz
DE102016218987A1 (de) verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz
DE102016219009A1 (de) Verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz
DE102016218989A1 (de) verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz
DE102016219006A1 (de) verbessert konditionierende Haarbehandlungsmittel mit Auswaschschutz
DE102015223843A1 (de) Leistungsstarke Haarbehandlungsmittel mit strukturstärkendem Effekt
DE102015223855A1 (de) Leistungsstarke Haarbehandlungsmittel mit Anti-Auswasch-Effekt

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070522

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

17Q First examination report despatched

Effective date: 20080418

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HENKEL AG & CO. KGAA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20110123